Categories: News

Reema Health Expands Leadership Team

Community-based health technology firm names seasoned healthcare leaders to the roles of Director of Field Operations and Chief Growth Officer

MINNEAPOLIS, April 20, 2022 /PRNewswire-PRWeb/ — Reema Health, a community-based health technology platform, announced the company has added two strategic new roles to its leadership team. Melissa Kjolsing has been named as Reema’s Chief Growth Officer and Nafula Namuninia has joined as Director of Field Operations.

As Chief Growth Officer, Melissa Kjolsing will spearhead strategic growth initiatives and lead business development for Reema. “As an industry leader who has been firmly embedded in Minnesota’s vibrant startup community for years, Melissa knows how to drive growth in a way that is both impactful and purposeful,” said Reema CEO Justin Ley.

“The inspiration for Reema Health and the population we serve are personally significant,” Kjolsing said. “I’m excited to contribute to Reema’s powerful mission and help improve health outcomes for people who have historically been hardest to reach.” Along with a proven track record in private enterprise, Kjolsing is known for a five-year stint as leader of the MN Cup, the largest statewide startup competition in the country.

As Director of Field Operations, Nafula Namuninia will lead Reema’s staff of experienced Community Guides and provide strategic guidance on the continuing development of Reema’s health technology platform. She is a seasoned healthcare leader with more than a decade supporting underserved populations in the U.S. and Kenya. “Nafula’s experiences working with a broad swath of private, nonprofit and public health programs will be an immense asset for Reema’s leadership team moving forward,” Ley said.

“Reema’s inquisitive approach and commitment to continuous improvement drew me to this opportunity right away,” Namuninia said. “I’m looking forward to helping Reema connect even more deeply with people who really need access to better social care, as a bridge to better health outcomes in the long term.”

Reema combines advanced technology with human interaction to transform how people navigate the gaps between health care and social care. CEO Ley added that the company is expanding its leadership roster in part to accommodate recent growth into new markets within the Midwest and East Coast regions.

About Reema Health:
Reema uses technology to power human relationships with the goal of improving health outcomes for people who are hardest to reach. Reema’s breakthrough health platform uses proprietary technology and predictive data modeling to identify people with the highest level of unmet social needs, power Community Guides with the right information to engage them meaningfully, connect them with the most relevant resources, and improve their health and their lives. For more information visit ReemaHealth.com.

Media Contact

Bonnie Harris, Reema Health, +1 (612) 801-0912, harris@waxmarketing.com

Jenn Dellwo, Reema Health, jenn.dellwo@reemahealth.com

 

SOURCE Reema Health

Staff

Recent Posts

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

Strategic Expansion into Cardio AI-Driven Healthcare SolutionsCollaboration to Enhance Patient-Centered Digital Healthcare TechnologiesWelcomes Key Industry…

2 hours ago

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

16 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

17 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

17 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

18 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

20 hours ago